Mesoblast (ASX:MSB) refinances debt facility with Oaktree

Latest Company News - Finance News Network

English - November 22, 2021 03:55 - 1000 KB
Business News News Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: SkyCity Entertainment (ASX:SKC) appoints new chairman

Next Episode: Stocks of the Hour: Meridian Energy, AMP & Mesoblast

22 Nov 2021 - Regenerative medicine developer Mesoblast (ASX:MSB) has agreed to a US $90 million debt facility with US fund manager Oaktree Capital Management to pay off an existing debt facility and to help the company expand in the US.